Dr. Andrew Huberman is Wrong & Here’s Why :)

Phenylethylamine (PEA) is debated regarding its efficacy as a psychoactive stimulant and its ability to influence synaptic dopamine levels. While it is marketed as a focus aid and work enhancement supplement, ingestion fails to provide any psychoactive effects because it is rapidly metabolized by monoamine oxidase B (MAO-B) in the small intestines before reaching the brain. Without the presence of an additional monoamine oxidase inhibitor, PEA functions primarily as a dietary supplement that lacks physiological potency or direct impact on brain chemistry. The video highlights how the substance is frequently misunderstood and incorrectly identified as a viable substitute for potent monoamine-altering substances.